Bayer Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Bayer Stock Forecast and Price Target
According to four esteemed experts, the average price target for Bayer to reach this year is 30.00€, with a potential upside of approximately 9.49%. This prediction is based on a high estimate of 68.00€ and a low estimate of 25.00€. If you want to invest in BAYN stock, you might also want to take a look at how its competitors are doing.
9.49% Upside
Bayer Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Bayer's Price has decreased from 52.33€ to 0.00€ – a 100.00% drop. For next year, analysts predict Fair Value of 69.78€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Bayer's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$733.51 | Buy/Sell | $636.99 | 14.18% |
| COST Stock Forecast | Costco Wholesale | Outperform |
11
|
$729.18 | Buy/Sell | $696.20 | 9.03% |
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$159.62 | Buy/Sell | $178.42 | 18.41% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£119.88 | Buy/Sell | £165.99 | 35.15% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$246.58 | Buy/Sell | $260.33 | 9.50% |
Bayer Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Bayer's Revenue has grown by 15.07%, rising from 41.40€B to 47.64€B. For next year, analysts predict Revenue of 50.31€B, which would mean an increase of 5.61%. Over the next seven years, experts predict that Bayer's Revenue will grow at a rate of 7.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.53 | Buy/Sell | $118.92 | 17.64% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$269.98 | Buy/Sell | $303.65 | 17.51% |
| DE Stock Forecast | Deere & | Outperform |
5
|
$393.33 | Buy/Sell | $424.33 | 4.61% |
.jpg)
Bayer Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's Dividend per Share has grown by 20.00%, rising from 2.00€ to 2.40€. For next year, analysts predict Dividend per Share of 2.54€, which would mean an increase of 5.83%. By 2030, professionals predict that Bayer's Dividend per Share will decrease by 0.00%, to 2.40€.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.85 | Buy/Sell | $58.15 | 21.52% |
| CSL Stock Forecast | CSL | Outperform |
12
|
$273.30 | Buy/Sell | $205.51 | -25.66% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$65.42 | Buy/Sell | $87.82 | 22.29% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$91.01 | Buy/Sell | $88.97 | 2.19% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$231.55 | Buy/Sell | $284.47 | 20.92% |
| BAS Stock Forecast | BASF | Outperform |
12
|
48.83€ | Buy/Sell | 49.50€ | 14.68% |
Bayer EBITDA Forecast for 2023 - 2025 - 2030
Bayer's EBITDA has grown In the last three years, rising from 10.13€B to 10.63€B – a growth of 5.00%. In the next year, analysts believe that EBITDA will reach 13.61€B – an increase of 28.04%. For the next seven years, experts predict that Bayer's EBITDA will grow at a rate of 42.53%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DOW Stock Forecast | Dow | Hold |
2
|
$57.29 | Buy/Sell | $57.75 | 4.73% |
| GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF3.96k | Buy/Sell | CHF3.14k | -2.83% |
| ALC Stock Forecast | Alcon | Outperform |
8
|
CHF72.00 | Buy/Sell | CHF90.64 | 33.83% |
Bayer EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Bayer's EBIT has decreased from 7.07€B to 612.00€M – a 91.34% drop! In the next year, analysts believe that EBIT will reach 9.30€B – an increase of 1419.55%. For the next seven years, the forecast is for EBIT to grow by 1702.45%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CTVA Stock Forecast | Corteva | Outperform |
12
|
$54.92 | Buy/Sell | $61.72 | 16.53% |
| SGO Stock Forecast | Compagnie de Saint-Gobain | Outperform |
10
|
75.24€ | Buy/Sell | 69.97€ | 10.31% |
| BEI Stock Forecast | Beiersdorf | Outperform |
17
|
140.50€ | Buy/Sell | 137.41€ | 6.05% |
Bayer EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Bayer's EPS has decreased from 6.39€ to 0.00€ – a 100.00% drop. For next year, analysts predict EPS of 8.52€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Bayer's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DD Stock Forecast | DuPont de Nemours | Outperform |
17
|
$73.71 | Buy/Sell | $75.38 | 8.53% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$208.90 | Buy/Sell | $299.62 | 38.10% |
| COLO B Stock Forecast | Coloplast A/S | Hold |
18
|
kr863.40 | Buy/Sell | kr812.28 | 5.40% |
.jpg)